Articoli recenti
- Long-term Outcomes After Rituximab Treatment for Patients With Systemic Sclerosis
- Treatment of Systemic Sclerosis-associated Interstitial Lung Disease
- CD19 CAR T-Cell Therapy in Autoimmune Disease
- Combining rituximab with mycophenolate for the treatment of interstitial lung disease
- Current Concepts on the Pathogenesis of Systemic Sclerosis
Commenti recenti
No comments to show.